If gastroparesis is severe, you may need to stop taking your GLP-1 medication
GLUCAGON-LIKE PEPTIDE RECEPTOR AND GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR AGONISTS These medications act by mimicking endogenous incretins peptide hormones secreted by the gastrointestinal system, controlled by neural mechanisms
How do I know if my prescription is compounded
Give the injection in the center of the triangle
Semaglutide is sold under three brand names, each with slightly different dosing profiles: Ozempic injectable, once-weekly, approved for type 2 diabetes and cardiovascular risk reduction Wegovy injectable, once-weekly, higher dose (up to 2.4 mg), approved for weight management Rybelsus oral tablet, taken daily, approved for type 2 diabetes All three share the same active ingredient and similar side-effect profiles, though Wegovy at higher doses tends to cause more frequent GI symptoms